Pain in Women pp 277-289 | Cite as

Breast Cancer-Related Pain

  • Julie K. Silver
  • Lisa Schulz Slowman


Women who undergo breast cancer treatments often experience pain that is not due to metastasis but rather other issues such as musculoskeletal sequelae. This chapter focuses on noncancer-related pain in breast cancer survivors. Some of the problems addressed include postmastectomy pain syndrome, arthralgia syndrome, and chemotherapy-induced peripheral neuropathy. Pain symptoms are often undertreated in this population and significantly impact quality of life and ability to function.


Neuropathic Pain Rotator Cuff Breast Cancer Survivor Axillary Lymph Node Dissection Transcutaneous Electrical Nerve Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ward SE, Goldberg N, et al. Patient-related barriers to management of cancer pain. Pain. 1993;52(3):319–24.PubMedCrossRefGoogle Scholar
  2. 2.
    Von Roenn JH, Cleeland CS, et al. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993.Google Scholar
  3. 3.
    Jacobsen R, Liubarskiene Z, et al. Barriers to cancer pain management: a review of empirical research. Medicina (Kaunas). 2009;45(6):427–33.Google Scholar
  4. 4.
    Goudas LC, Bloch R, Gialeli-Goudas LLM, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Invest. 2005;23:182–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006;7:797–809.PubMedCrossRefGoogle Scholar
  6. 6.
    Cheville AL. Pain management in cancer rehabilitation. Arch Phys Med Rehabil. 2001;82(3 suppl 1):S84–7.PubMedGoogle Scholar
  7. 7.
    Tasmuth T, von Smitten K, Hietanen P, Katja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol. 1995;6(5):453–9.PubMedGoogle Scholar
  8. 8.
    Sclafani LM, Baron RH. Sentinel lymph node biopsy and axillary dissection added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J. 2008;14:216–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Gartner R, Jensen MB, et al. Prevalence of and factor associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Lacomba MT, del Moral OM, Sazo JL, et al. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26:320–5.CrossRefGoogle Scholar
  11. 11.
    Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8(2):189–98.PubMedCrossRefGoogle Scholar
  12. 12.
    Stubblefield M, Levine A, Custodio C, Fitzpatrick T. The role of botulinum type A in the radiation fibrosis syndrome: a preliminary report. Arch Phys Med Rehab. 2008;89:417–21.CrossRefGoogle Scholar
  13. 13.
    Couceiro TCM, Menezes TC, Valênça MM. Post-mastectomy pain syndrome. The magnitude of the problem. Rev Bras Anestesiol. 2009;59(3):358–65.PubMedCrossRefGoogle Scholar
  14. 14.
    Macdonald L, Bruce J, Scott NW, Smith WCS, Chambers WA. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005;92:225–30.PubMedGoogle Scholar
  15. 15.
    Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66(2–3):195–205.PubMedCrossRefGoogle Scholar
  16. 16.
    Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104(1–2):1–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20(6):719–25.PubMedGoogle Scholar
  18. 18.
    Taxol [package insert]. Princenton, NJ: Bristol-Myers Squibb Company; 2011.Google Scholar
  19. 19.
    Hilkens PH, Verweij J, Stoter G, Vecht CJ, van Putten WL, van den Bent MJ. Peripheral ­neurotoxicity induced by docetaxel. Neurology. 1996;46(1):104–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Burstein HJ, Winer EP. Aromatase inhibitors and arthralgias: a new frontier in symptom ­management for breast cancer survivors. J Clin Oncol. 2007;25(25):3797–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Mao JJ, Stricker C, Bruner D, et al. Patterns and risk factors associated with aromatase ­inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009;115(16):3631–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Daut R, Cleeland C, Flanery R. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197–210.PubMedCrossRefGoogle Scholar
  23. 23.
    Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure ­cancer pain intensity. Cancer Nurs. 1997;20(2):88–93.PubMedCrossRefGoogle Scholar
  24. 24.
    Hollen PJ, Gralla RJ, et al. A comparison of visual analog and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life? Qual Life Res. 2005;14(3):837–47.PubMedCrossRefGoogle Scholar
  25. 25.
    Tittle MB, McMillan SC, Hagan S. Validating the Brief Pain Inventory for use with surgical patients with cancer. Oncol Nurs Forum. 2003;30:325–30.PubMedCrossRefGoogle Scholar
  26. 26.
    Alfano CM, Smith AW, et al. Physical activity, long-term symptoms, and physical health related quality of life among breast cancer survivors: a prospective analysis. J Cancer Surviv. 2007;1(2):116–28.PubMedCrossRefGoogle Scholar
  27. 27.
    “WHO’s pain ladder.” World Health Organization. Accessed 15 Jan 2010.
  28. 28.
    Griffith K, Wenzel J, Shang JJ, et al. Impact of a walking intervention on a cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors. Cancer. 2009;115(20):4874–84.PubMedCrossRefGoogle Scholar
  29. 29.
    Stubblefield MD, O’Dell MW. Cancer rehabilitation. New York: Demos Medical Publishing; 2009. p. 481.Google Scholar
  30. 30.
    Watkins T, Maxeiner A. Musculoskeletal effects of ovarian cancer and treatment: a physical therapy perspective. Rehab Oncol. 2003;21:12.Google Scholar
  31. 31.
    Stubblefield MD, O’Dell MW. Cancer rehabilitation. New York: Demos Medical Publishing; 2009. p. 507–13.Google Scholar
  32. 32.
    Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153–69.PubMedCrossRefGoogle Scholar
  33. 33.
    Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD006146.PubMedGoogle Scholar
  34. 34.
    Eisenberg E, McNicol ED, Carr DB. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur J Pain. 2006;10(8):667–76.PubMedCrossRefGoogle Scholar
  35. 35.
    Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side-effects. CMAJ. 2006;174(11):1589–94.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Julie K. Silver
    • 1
  • Lisa Schulz Slowman
    • 2
  1. 1.Department of Physical Medicine and RehabilitationHarvard Medical SchoolNorthboroUSA
  2. 2.Outpatient Rehabilitation, Whittier Rehabilitation HospitalWestboroughUSA

Personalised recommendations